annual total liabilities:
$205.50M+$38.05M(+22.72%)Summary
- As of today (June 28, 2025), PCVX annual total liabilities is $205.50 million, with the most recent change of +$38.05 million (+22.72%) on December 31, 2024.
- During the last 3 years, PCVX annual total liabilities has risen by +$165.18 million (+409.68%).
- PCVX annual total liabilities is now at all-time high.
Performance
PCVX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$178.08M-$27.42M(-13.34%)Summary
- As of today (June 28, 2025), PCVX quarterly total liabilities is $178.08 million, with the most recent change of -$27.42 million (-13.34%) on March 31, 2025.
- Over the past year, PCVX quarterly total liabilities has increased by +$70.75 million (+65.93%).
- PCVX quarterly total liabilities is now -13.34% below its all-time high of $205.50 million, reached on December 31, 2024.
Performance
PCVX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PCVX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.7% | +65.9% |
| 3 y3 years | +409.7% | +312.5% |
| 5 y5 years | +19.4% | +621.4% |
PCVX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +409.7% | -13.3% | +312.5% |
| 5 y | 5-year | at high | +409.7% | -13.3% | +621.4% |
| alltime | all time | at high | +409.7% | -13.3% | +621.4% |
PCVX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $178.08M(-13.3%) |
| Dec 2024 | $205.50M(+22.7%) | $205.50M(+44.6%) |
| Sep 2024 | - | $142.11M(+40.5%) |
| Jun 2024 | - | $101.14M(-5.8%) |
| Mar 2024 | - | $107.32M(-35.9%) |
| Dec 2023 | $167.45M(+218.6%) | $167.45M(+79.4%) |
| Sep 2023 | - | $93.34M(+34.4%) |
| Jun 2023 | - | $69.44M(+9.5%) |
| Mar 2023 | - | $63.39M(+20.6%) |
| Dec 2022 | $52.56M | $52.56M(-0.4%) |
| Sep 2022 | - | $52.75M(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $45.12M(+4.5%) |
| Mar 2022 | - | $43.17M(+7.1%) |
| Dec 2021 | $40.32M(-14.2%) | $40.32M(-16.2%) |
| Sep 2021 | - | $48.11M(+17.3%) |
| Jun 2021 | - | $41.03M(-26.0%) |
| Mar 2021 | - | $55.41M(+17.9%) |
| Dec 2020 | $46.98M(-72.7%) | $46.98M(+18.2%) |
| Sep 2020 | - | $39.74M(+20.3%) |
| Jun 2020 | - | $33.04M(+33.8%) |
| Mar 2020 | - | $24.68M(-85.7%) |
| Dec 2019 | $172.07M(+33.9%) | $172.07M |
| Dec 2018 | $128.53M | - |
FAQ
- What is Vaxcyte annual total liabilities?
- What is the all time high annual total liabilities for Vaxcyte?
- What is Vaxcyte annual total liabilities year-on-year change?
- What is Vaxcyte quarterly total liabilities?
- What is the all time high quarterly total liabilities for Vaxcyte?
- What is Vaxcyte quarterly total liabilities year-on-year change?
What is Vaxcyte annual total liabilities?
The current annual total liabilities of PCVX is $205.50M
What is the all time high annual total liabilities for Vaxcyte?
Vaxcyte all-time high annual total liabilities is $205.50M
What is Vaxcyte annual total liabilities year-on-year change?
Over the past year, PCVX annual total liabilities has changed by +$38.05M (+22.72%)
What is Vaxcyte quarterly total liabilities?
The current quarterly total liabilities of PCVX is $178.08M
What is the all time high quarterly total liabilities for Vaxcyte?
Vaxcyte all-time high quarterly total liabilities is $205.50M
What is Vaxcyte quarterly total liabilities year-on-year change?
Over the past year, PCVX quarterly total liabilities has changed by +$70.75M (+65.93%)